Inanovate, Inc.
PrivateLast Round
VC Round
Jul 2, 2025
Total Funding Raised
$6.4M
Company Overview
Inanovate, Inc. is a biotechnology company that develops diagnostic tests for cancer and other diseases using its proprietary Bio-ID multiplexed protein quantification platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Inanovate, Inc. Comparables
Compare Inanovate, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Quansys Biosciences | 77% | |
| Thermo Fisher Scientific Inc. | 74% | |
| ProteoWise | 73% |
Inanovate, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jul 2, 2025 | ||||
| VC Round | Nov 15, 2024 | ||||
| VC Round | Jun 12, 2024 | ||||
| Debt | Apr 27, 2020 | ||||
| Grant | Aug 21, 2019 | ||||
Series C | Apr 3, 2019 |
Key People
Founding team and executive leadership
Inanovate, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| South Dakota Equity Partners | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 2, 2025
$808K raised in a VC Round.
- Nov 15, 2024
$3.5M raised in a VC Round.
Inanovate, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Inanovate, Inc.'s valuation, stock price, and market status.
Is Inanovate, Inc. a public or private company?
Inanovate, Inc. is a private company.
What is the current stock price of Inanovate, Inc.?
Inanovate, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Inanovate, Inc. worth (valuation)?
Valuation information for Inanovate, Inc. is not publicly available.
Can I buy Inanovate, Inc. stock?
Inanovate, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Inanovate, Inc.'s last funding round?
Inanovate, Inc.'s most recent funding round was VC Round on July 2, 2025.
Who are the main investors in Inanovate, Inc.?
Key investors in Inanovate, Inc. include National Cancer Institute, South Dakota Equity Partners.
Will Inanovate, Inc. IPO soon?
No public IPO plans have been announced for Inanovate, Inc..
How can I track Inanovate, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Inanovate, Inc.'s secondary market activity and sign up for updates.